rilonacept sold brand name arcalyst medication used treat cryopyrinassociated periodic syndromes including familial cold autoinflammatory syndrome syndrome deficiency receptor antagonist recurrent rilonacept interleukin rilonacept dimeric fusion protein consisting ligandbinding domains extracellular portions human receptor component receptor accessory protein linked inline fragmentcrystallizable portion fc region human binds neutralizes rilonacept given orphan drug designation us food drug administration fda used treatment cryopyrinassociated periodic syndromes caps including familial cold autoinflammatory syndrome rilonacept first drug approved fda treat recurrent rilonacept approved medical use united states february may fda advisory panel voted approval rilonacept treatment gout stating benefits outweigh risks associated antineoplastic immunomodulatory drug article stub help wikipedia expanding ithttpsenwikipediaorgwikirilonacept